Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' DUPONT B' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 205 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ally, R; Schurmann, D; Kreisel, W; Carosi, G; Aguirrebengoa, K; Dupont, B; Hodges, M; Troke, P; Romero, AJ
      A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients

      CLINICAL INFECTIOUS DISEASES
    2. Merrer, J; Dupont, B; Nieszkowska, A; De Jonghe, B; Outin, H
      Candida albicans prosthetic arthritis treated with fluconazole alone

      JOURNAL OF INFECTION
    3. David, D; Nait-Ighil, L; Dupont, B; Maral, J; Gachot, B; Theze, J
      Rapid effect of interleukin-2 therapy in human immunodeficiency virus-infected patients whose CD4 cell counts increase only slightly in response to combined antiretroviral treatment

      JOURNAL OF INFECTIOUS DISEASES
    4. Lortholary, O; Dromer, F; Mathoulin-Pelissier, S; Fitting, C; Improvisi, L; Cavaillon, JM; Dupont, B
      Immune mediators in cerebrospinal fluid during cryptococcosis are influenced by meningeal involvement and human immunodeficiency virus serostatus

      JOURNAL OF INFECTIOUS DISEASES
    5. Vyas, YM; Mehta, KM; Morgan, M; Maniar, H; Butros, L; Jung, S; Burkhardt, JK; Dupont, B
      Spatial organization of signal transduction molecules in the NK cell immune synapses during MHC class I-regulated noncytolytic and cytolytic interactions

      JOURNAL OF IMMUNOLOGY
    6. Botterel, F; Romand, S; Cornet, M; Recanati, G; Dupont, B; Bouree, P
      Dermatophyte pseudomycetoma of the scalp: case report and review

      BRITISH JOURNAL OF DERMATOLOGY
    7. Besson, C; Goubar, A; Gabarre, J; Rozenbaum, W; Pialoux, G; Chatelet, FP; Katlama, C; Charlotte, F; Dupont, B; Brousse, N; Huerre, M; Mikol, J; Camparo, P; Mokhtari, K; Tulliez, M; Salmon-Ceron, D; Boue, F; Costagliola, D; Raphael, M
      Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy

      BLOOD
    8. Petersdorf, EW; Kollman, C; Hurley, CK; Dupont, B; Nademanee, A; Begovich, AB; Weisdorf, D; McGlave, P
      Effect of BLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience

      BLOOD
    9. Dupont, B; Richardson, M; Verweij, PE; Meis, JFGM
      Invasive aspergillosis

      MEDICAL MYCOLOGY
    10. Dupont, B; Brown, HHC; Westermann, K; Martins, MD; Rex, JH; Lortholary, O; Kauffmann, CA
      Mycoses in AIDS

      MEDICAL MYCOLOGY
    11. Schaub, R; Dupont, B; Roodman, GD; Leach, RJ; Reddy, SV
      Assignment of OSTF1 to human chromosome bands 12q24.1 -> q24.2 by in situ hybridization

      CYTOGENETICS AND CELL GENETICS
    12. David, D; Chevrier, D; Treilhou, MP; Joussemet, M; Dupont, B; Theze, J; Guesdon, JL
      IL-18 underexpression reduces IL-2 levels during HIV infection: a criticalstep towards the faulty cell-mediated immunity?

      AIDS
    13. Jager, E; Nagata, Y; Gnjatic, S; Wada, H; Stockert, E; Karbach, J; Dunbar, PR; Lee, SY; Jungbluth, A; Jager, D; Arand, M; Ritter, C; Cerundolo, V; Dupont, B; Chen, YT; Old, LJ; Knuth, A
      Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    14. Gnjatic, S; Nagata, Y; Jager, E; Stockert, E; Shankara, S; Roberts, BL; Mazzara, GP; Lee, SY; Dunbar, PR; Dupont, B; Cerundolo, V; Ritter, G; Chen, YT; Knuth, A; Old, LJ
      Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    15. Patterson, TF; Kirkpatrick, WR; White, M; Hiemenz, JW; Wingard, JR; Dupont, B; Rinaldi, MG; Stevens, DA; Graybill, JR
      Invasive aspergillosis - Disease spectrum, treatment practices, and outcomes

      MEDICINE
    16. Lortholary, O; Improvisi, L; Nicolas, M; Provost, F; Dupont, B; Dromer, F
      Fungemia during murine cryptococcosis sheds some light on pathophysiology

      MEDICAL MYCOLOGY
    17. Reynes, J; Raffi, F; Joly, V; Nevez, G; Dupont, B
      Itraconazole oral solution for treatment of fluconazole resistant oral/esophageal candidosis in HIV-infected patients: Results of a prospective multicenter study I. Clinical assessment

      JOURNAL DE MYCOLOGIE MEDICALE
    18. Bodmer, JG; Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Hansen, JA; Mach, B; Mayr, WR; Parham, P; Petersdorf, EW; Sasazuki, T; Schreuder, GMT; Strominger, JL; Svejgaard, A; Terasaki, PI
      Nomenclature for factors of the HLA system, 1998

      EUROPEAN JOURNAL OF IMMUNOGENETICS
    19. David, D; Pires, R; Treilhou, MP; Dupont, B; Joussemet, M; Pialoux, G; Theze, J; Bouvet, JP
      Downregulation of the expression of the main immunoglobulin V-H family in HIV-infected patients: Modulation by triple combination therapy

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    20. Lortholary, O; Nicolas, M; Soreda, S; Improvisi, L; Ronin, O; Petitjean, O; Dupont, B; Tod, M; Dromer, F
      Fluconazole, with or without dexamethasone for experimental cryptococcosis: impact of treatment timing

      Journal of antimicrobial chemotherapy
    21. Odds, FC; Dupont, B; Rinaldi, MG; Stevens, DA; Warnock, DW; Woestenborghs, R
      Bioassays for itraconazole blood levels: an interlaboratory collaborative study

      Journal of antimicrobial chemotherapy
    22. Lortholary, O; Denning, DW; Dupont, B
      Endemic mycoses: a treatment update

      Journal of antimicrobial chemotherapy
    23. Bodmer, JG; Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Hansen, JA; Mach, B; Mayr, WR; Parham, P; Petersdorf, EW; Sasazuki, T; Schreuder, GMT; Strominger, JL; Svejgaard, A; Terasaki, PI
      Nomenclature for Factors of the HLA System, 1998

      HUMAN IMMUNOLOGY
    24. Dupont, B
      Clinical efficacy of amphotericin B colloidal dispersion against infections caused by Candida spp

      CHEMOTHERAPY
    25. Besson, C; Pialoux, G; Dupont, B; Pol, S; Hermine, O; Arnulf, B; Landau, A; McCormick, JB
      Lack of association between HCV infection and HIV-related lymphoma

      BRITISH JOURNAL OF HAEMATOLOGY
    26. Prentice, HG; Caillot, D; Dupont, B; Menichetti, F; Schuler, U
      Oral and intravenous itraconazole for systemic fungal infections in neutropenic haematological patients: Meeting report

      ACTA HAEMATOLOGICA
    27. Bodmer, JG; Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Hansen, JA; Mach, B; Mayr, WR; Parham, P; Petersdorf, EW; Sasazuki, T; Schreuder, GMT; Strominger, JL; Svejgaard, A; Terasaki, PI
      Nomenclature for factors of the HLA system, 1998

      TISSUE ANTIGENS
    28. WARNOCK DW; DUPONT B; KAUFFMAN CA; SIRISANTHANA T
      IMPORTED MYCOSES IN EUROPE

      MEDICAL MYCOLOGY
    29. GORI S; DROUHET E; GUEHO E; HUERRE M; LOFARO A; PARENTI M; DUPONT B
      CUTANEOUS DISSEMINATED MYCOSIS IN A PATIENT WITH AIDS DUE TO A NEW DIMORPHIC FUNGUS

      Journal de mycologie medicale
    30. DROUHET E; GUEHO E; GORI S; HUERRE M; PROVOST F; BORGERS M; DUPONT B
      MYCOLOGICAL, ULTRASTRUCTURAL AND EXPERIMENTAL ASPECTS OF A NEW DIMORPHIC FUNGUS EMMONSIA-PASTEURIANA SP. NOV. ISOLATED FROM A CUTANEOUS DISSEMINATED MYCOSIS IN AIDS

      Journal de mycologie medicale
    31. DAVID D; BANI L; MOREAU JL; TREILHOU MP; NAKARAI T; JOUSSEMET M; RITZ J; DUPONT B; PIALOUX G; THEZE J
      IMPACT OF TRIPLE COMBINATION THERAPY ON THE IL-2 REACTIVITY OF CD4 AND CD8 T-LYMPHOCYTES FROM HIV-INFECTED PATIENTS

      European cytokine network
    32. DAVID D; BANI L; MOREAU JL; TREILHOU MP; DEMAISON C; SUN K; FEVRIER M; SALVUCCI O; CAYOTA A; NAKARAI T; CHOUAIB S; DEMONTALEMBERT M; JOUSSEMET M; SUGAMURA K; RITZ J; DUPONT B; PIALOUX G; THEZE J
      DYSREGULATION OF INTERLEUKIN-2 RECEPTOR-BETA AND INTERLEUKIN-2 RECEPTOR-GAMMA EXPRESSION DURING HIV INFECTION

      European cytokine network
    33. Jabado, N; Casanova, JL; Haddad, E; Dulieu, F; Fournet, JC; Dupont, B; Fischer, A; Hennequin, C; Blanche, S
      Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease

      CLINICAL INFECTIOUS DISEASES
    34. LAFOND E; COULETTE R; GRAND C; NADAL MH; DUPONT B; LEPOUTRE F; BALAGEAS D; PETILLON O
      APPLICATION OF A 2-LAYER SEMIANALYTICAL MODEL FOR THE IMPROVEMENT OF LASER-ULTRASONIC GENERATION

      NDT & E international
    35. KING PD; SADRA A; TENG JMC; BELL GM; DUPONT B
      CD2-MEDIATED ACTIVATION OF THE TEC-FAMILY TYROSINE KINASE ITK IS CONTROLLED BY PROLINE-RICH STRETCH-4 OF THE CD2 CYTOPLASMIC TAIL

      International immunology (Print)
    36. Connelly, RJ; Hayden, MS; Scholler, JK; Tsu, TT; Dupont, B; Ledbetter, JA; Kanner, SB
      Mitogenic properties of a bispecific single-chain Fv-Ig fusion generated from CD2-specific mAb to distinct epitopes

      INTERNATIONAL IMMUNOLOGY
    37. MARTI F; XU CW; SELVAKUMAR A; BRENT R; DUPONT B; KING PD
      LCK PHOSPHORYLATED HUMAN KILLER-CELL INHIBITORY RECEPTORS RECRUIT ANDACTIVATE PHOSPHATIDYLINOSITOL 3-KINASE

      The FASEB journal
    38. TENG JMC; LIU XR; SELVAKUMAR A; KING PD; DUPONT B
      CHARGED RESIDUES IN THE TRANSMEMBRANE DOMAIN OF KILLER-CELL INHIBITORY RECEPTORS REGULATE SIGNAL-TRANSDUCTION PATHWAYS

      The FASEB journal
    39. LANDAU A; PIALOUX G; CARNOT F; POVEDA JD; ZYLBERBERG H; POL S; BLOCH F; PETITE JP; DUPONT B
      IMPACT OF CHRONIC HEPATITIS-C IN 93 PATIENTS INFECTED WITH HIV-1 - A CLINICAL, HISTOLOGICAL AND VIROLOGICAL STUDY

      Hepatology
    40. CARTLEDGE JD; DENNING DW; DUPONT B; CLUMECK N; DEWIT S; MIDGLEY J; HAWKINS DA; GAZZARD BG
      TREATMENT OF HIV-RELATED FLUCONAZOLE-RESISTANT ORAL CANDIDOSIS WITH D0870, A NEW TRIAZOLE ANTIFUNGAL

      AIDS
    41. COIFFIER T; ROGER G; BEUST L; QUINET B; ADAM D; DUPONT B; GARABEDIAN EN
      PHARYNGO-LARYNGEAL HISTOPLASMOSIS - ONE CASE IN AN IMMUNOCOMPETENT CHILD

      International journal of pediatric otorhinolaryngology
    42. MARTI F; XU CW; SELVAKUMAR A; BRENT R; DUPONT B; KING PD
      LCK-PHOSPHORYLATED HUMAN KILLER CELL-INHIBITORY RECEPTORS RECRUIT ANDACTIVATE PHOSPHATIDYLINOSITOL 3-KINASE

      Proceedings of the National Academy of Sciences of the United Statesof America
    43. DAVID D; BANI L; MOREAU JL; TREILHOU MP; NAKARAI T; JOUSSEMET M; RITZ J; DUPONT B; PIALOUX G; THEZE J
      REGULATORY DYSFUNCTION OF THE INTERLEUKIN-2 RECEPTOR DURING HIV-INFECTION AND THE IMPACT OF TRIPLE COMBINATION THERAPY

      Proceedings of the National Academy of Sciences of the United Statesof America
    44. DUPONT B
      INDUCTION OF A MINOR INTO THE MAJOR-LEAGUE - GENOMIC IDENTIFICATION OF A HUMAN MINOR HISTOCOMPATIBILITY ANTIGEN

      Tissue antigens
    45. DUPONT B; HANSEN JA
      UNTITLED

      Tissue antigens
    46. STEFFENS U; VYAS Y; DUPONT B; SELVAKUMAR A
      NUCLEOTIDE AND AMINO-ACID-SEQUENCE ALIGNMENT FOR HUMAN KILLER-CELL INHIBITORY RECEPTORS (KIR), 1998

      Tissue antigens
    47. Vyas, Y; Selvakumar, A; Steffens, U; Dupont, B
      Multiple transcripts of the killer cell immunoglobulin-like receptor family, KIR3DL1 (NKB1), are expressed by natural killer cells of a single individual

      TISSUE ANTIGENS
    48. NIKOL J; POLIVKA M; MOULIGNIER A; CASTAGNET P; DUPONT B; MORINET F
      BCL2 AND BAX EXPRESSION IN PRIMARY CENTRAL NERVOUS NON-HODGKINS-LYMPHOMAS (PCNHL)

      Brain pathology
    49. BODMER JG; MARSH SGE; ALBERT ED; BODMER WF; BONTROP RE; CHARRON D; DUPONT B; ERLICH HA; FAUCHET R; MACH B; MAYR WR; PARHAM P; SASAZUKI T; SCHREUDER GMT; STROMINGER JL; SVEJGAARD A; TERASAKI PI
      NOMENCLATURE FOR FACTORS OF THE HLA SYSTEM, 1996

      European journal of immunogenetics
    50. FOURNIER S; PIALOUX G; FEUILLIE V; FLEURY J; DUPONT B
      EDWARDSIELLA-TARDA SEPTICEMIA WITH CELLULITIS IN A PATIENT WITH AIDS

      European journal of clinical microbiology & infectious diseases
    51. GUEHO E; LECLERC MC; DEHOOG GS; DUPONT B
      MOLECULAR TAXONOMY AND EPIDEMIOLOGY OF BLASTOMYCES AND HISTOPLASMA SPECIES

      Mycoses
    52. LORTHOLARY O; DUPONT B
      ANTIFUNGAL PROPHYLAXIS DURING NEUTROPENIA AND IMMUNODEFICIENCY

      Clinical microbiology reviews
    53. ZUCK P; RIO Y; TRINH A; DELAVAULT P; PETITFRERE I; CLAUDE JL; CROCE C; CAUBEL F; DOVAN R; GROSSIER JM; HENLE D; KOCH C; MULLER D; PERREIN C; PIERRON J; PRIME T; RICHTER D; ROSZAK E; MONIEZ D; DOURNOVO P; MONTEAU N; CAVALIER B; ALLEGRINI C; GRIMALDI JF; GUERIN P; GUIRAUD JP; PUGET A; LEONARDELLI M; ALFIERISIADOUS M; BERACASSAT C; DAVIGNON J; GIRARD D; PELLETIER M; NAUDIN G; VINCENT J; FERRU J; ABITBOL JP; AVAKIAN A; BENEVISE B; CONNAN JB; DEVALMONT D; SAUTEREAU O; HERMAN D; LAUBY M; BALTUS C; GAILLARD JR; PLAN P; ROLLAND C; TAURILPIBRE EL; VIDAL M; GARCIN L; LIEB F; LIEBBAZILE C; AURIOL P; CAUSSE P; DADOLLE C; PARTRAT Y; PRIEUR T; VERGNON JM; ROS A; HANRION P; PLANEL P; BERAUD A; HOUPPERT Y; DUPONT B; FOUCHARD JL; MANTOVANI M; SILVAIN C; DEBIEUVRE D; CHANTELAT P; BLANCHON F; GRIGNET JP; ROYER E; AMAR P; BENSOUSSAN R; BISMUTH D; BRILLAUX F; DORFMANN M; DUCLOS G; FONTAINE M; GARCON G; GIRARD P; GUTH PC; KICHELEWSKI S; LEVY D; NEDELEC P; VASSEUR G; WALTER P; BEAUCE A; TRAN VT; LABESCAT J; COMPAN D; SCHEIMBERG A; MOURET G; DEPEUFEILHOUX A; MENZEL R
      CEFIXIM VERSUS AMOXICILLIN-CLAVULANATE IN THE TREATMENT OF ACUTE EXACERBATION OF CHRONIC-BRONCHITIS, IN PATIENTS WITH RISK-FACTORS

      Medecine et maladies infectieuses
    54. FOURNIER S; TREILHOU MP; PIALOUX G; FLEURY J; DUPONT B
      PSEUDOMONAS-AERUGINOSA INFECTION IN 25 AI DS PATIENTS

      Medecine et maladies infectieuses
    55. DROMER F; IMPROVISI L; DUPONT B; ELIASZEWICZ M; PIALOUX G; FOURNIER S; FEUILLIE V
      ORAL-TRANSMISSION OF CANDIDA-ALBICANS BETWEEN PARTNERS IN HIV-INFECTED COUPLES COULD CONTRIBUTE TO DISSEMINATION OF FLUCONAZOLE-RESISTANT ISOLATES

      AIDS
    56. CHEBBI F; POVEDA JD; SUZUKI T; TAI H; YOSHIE H; ELTENN R; DESAINTMARTIN J; GUETARD D; HARA K; DUPONT B; DETHE G
      SEARCH FOR INFECTIOUS HIV IN GINGIVAL CREVICULAR FLUID AND SALIVA OF ADVANCED AIDS PATIENTS WITH SEVERE PERIODONTITIS

      AIDS
    57. DEWIT S; DUPONT B; CARTLEDGE JD; HAWKINS DA; GAZZARD BG; CLUMECK N; DENNING DW
      A DOSE COMPARISON STUDY OF A NEW TRIAZOLE ANTIFUNGAL (D0870) IN HIV-POSITIVE PATIENTS WITH ORAL CANDIDIASIS

      AIDS
    58. DEVINCENZI I; JADAND C; COUTURIER E; BRUNET JB; GALLAIS H; GASTAUT JA; GOUJARD C; DEVEAU C; MEYER L; ROUZIOUX C; BARY M; BURGARD M; DORMONT J; DELFRAISSY JF; LEVY A; BOUE F; DELLAMONICA P; PERBOST I; CARLES M; MONDAIN V; GUILLEVIN L; JAROUSSE B; TROGOFF B; LEBRAS P; QUERTAINMONT Y; VILDE JL; LEPORT C; COLASSANTE U; KAZATCHKINE M; VELLAY A; BUISSON M; CASSUTO JP; REBOULOT B; SERENI D; GOMEZ V; BACHMEYER C; MARS ME; GALLAIS J; SOBEL A; DUVAL J; MAJERHOLE C; DEFORGES L; LEFRERE JJ; LERABLE J; JOUBERT L; DUPONT B; BEUZELIN C; FOURNIER S; VITTECOQ D; BOLLIOT C; PECHALAT MT; HERSON S; COUTELLIER A; KATLAMA C; BRUCKER G; DHIVER C; DROGOUL MP
      PREGNANCY AND CONTRACEPTION IN A FRENCH COHORT OF HIV-INFECTED WOMEN

      AIDS
    59. MEYER L; MAGIEROWSKA M; HUBERT JB; ROUZIOUX C; DEVEAU C; SANSON F; DEBRE P; DELFRAISSY JF; THEODOROU I; BARY M; BURGARD M; DORMONT J; BOUE F; LEVY A; DELLAMONICA P; PERBOST I; CARLES M; MONDAIN V; GUILLEVIN L; JAROUSSE B; TROGOFF B; LEBRAS P; GOUJARD C; QUERTAINMONT Y; VILDE JL; LEPORT C; COLASSANTE U; KAZATCHKINE M; VELLAY A; BUISSON M; CASSUTO JP; REBOULOT B; QUARANTA M; SERENI D; GOMEZ V; BACHMEYER C; GALLAIS H; MARS ME; GALLAIS J; SOBEL A; DUVAL J; MAJERHOLE C; DEFORGES L; LEFRERE JJ; LERABLE J; JOUBERT L; DUPONT B; BEUZELIN C; FOURNIER S; VITTECOQ D; BOLLIOT C; PECHALAT MT; HERSON S; COUTELLIER A; KATLAMA C; BRUCKER G; GASTAUT JA; DHIVER C; DROGOUL MP
      EARLY PROTECTIVE EFFECT OF CCR-5 DELTA-32 HETEROZYGOSITY ON HIV-1 DISEASE PROGRESSION - RELATIONSHIP WITH VIRAL LOAD

      AIDS
    60. PIALOUX G; FOURNIER S; MOULIGNIER A; POVEDA JD; CLAVEL F; DUPONT B
      CENTRAL-NERVOUS-SYSTEM AS A SANCTUARY FOR HIV-1 INFECTION DESPITE TREATMENT WITH ZIDOVUDINE, LAMIVUDINE AND INDINAVIR

      AIDS
    61. TENG JMC; LIU XR; SELVAKUMAR A; KING PD; DUPONT B
      STRUCTURE-FUNCTION ANALYSES OF NK CELL RECEPTORS SPECIFIC FOR HLA CLASS-I MOLECULES

      Human immunology
    62. PETERSDORF EW; KOLLMAN C; HURLEY C; DUPONT B; BEGOVICH A; HANSEN J; HARTZMAN R; NADEMANEE A; MCGLAVE P
      ANALYSIS OF 390 MARROW TRANSPLANTS FOR THE TREATMENT OF CHRONIC MYELOID-LEUKEMIA FROM UNRELATED DONORS FACILITATED BY THE US NATIONAL-MARROW-DONOR-PROGRAM(R) (NMDP) - EFFECT OF HLA-DRB1 ALLELE DISPARITY ON CLINICAL OUTCOME

      Human immunology
    63. LAZARO A; HUNTER J; DUPONT B; FERNANDEZVINA M; HARTZMAN R; HEGLAND J; HILDEBRAND WH; HURLEY C; NG J; NOREEN H; PETERSDORF E; TRACHTENBERG E
      HIGH-RESOLUTION MOLECULAR TYPING OF BONE-MARROW RECIPIENTS AND DONORS

      Human immunology
    64. SELVAKUMAR A; STEFFENS U; DUPONT B
      KILLER-CELL INHIBITORY RECEPTORS - ALLELIC POLYMORPHISM AND GENE STRUCTURE VARIATIONS

      Human immunology
    65. STEFFENS U; SELVAKUMAR A; VYAS Y; MICKELSON E; HANSEN JA; DUPONT B
      PCR-DNA TYPING OF KIRS ON NK CELLS IN HLA CLASS-I HOMOZYGOUS AND HETEROZYGOUS INDIVIDUALS

      Human immunology
    66. BODMER JG; MARSH SGE; ALBERT ED; BODMER WF; BONTROP RE; CHARRON D; DUPONT B; ERLICH HA; FAUCHET R; MACH B; MAYR WR; PARHAM P; SASAZUKI T; SCHREUDER GMT; STROMINGER JL; SVEJGAARD A; TERASAKI PI
      NOMENCLATURE FOR FACTORS OF THE HLA SYSTEM, 1996

      Human immunology
    67. CARRE N; ROBAIN M; DUSSAIX E; SALMONCERON D; MEYER L; ROUZIOUX C; BARY M; BURGARD M; DELLAMONICA P; DURANT J; GALLAIS H; MARS ME; GALLAIS J; DORMONT J; LEVY A; BOUE F; LEFRERE JJ; LERABLE J; JOUBERT L; CASSUTO JP; REBOULOT B; QUARANTA M; DUPONT B; BEUZELIN C; FOURNIER S; VITTECOQ D; BOLLIOT C; PECHALAT MT; HERSON S; COUTELLIER A; GASTAUT JA; DHIVER C; DROGOUL MP; SERENI D; GOMEZ V; BACHMEYER C; VILDE JL; LEPORT C; COLASSANTE U; KATLAMA C; BRUCKER G; SOBEL A; DUVAL J; MAJERHOLC C; DEFORGES L; KAZATCHKINE M; VELLAY A; BUISSON M; DELFRAISSY JF; LEBRAS P; GOUJARD C; QUERTAINMONT Y; GUILLEVIN L; JAROUSSE B; TROGOFF B
      SEXUAL FACTORS ASSOCIATED WITH CYTOMEGALOVIRUS SEROPOSITIVITY IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED MEN

      Sexually transmitted diseases
    68. DUPONT B
      IMMUNOLOGY OF HEMATOPOIETIC STEM-CELL TRANSPLANTATION - A BRIEF REVIEW OF ITS HISTORY

      Immunological reviews
    69. SELVAKUMAR A; STEFFENS U; DUPONT B
      POLYMORPHISM AND DOMAIN VARIABILITY OF HUMAN KILLER-CELL INHIBITORY RECEPTORS

      Immunological reviews
    70. GARCIAHERMOSO D; MATHOULINPELISSIER S; COUPRIE B; RONIN O; DUPONT B; DROMER F
      DNA TYPING SUGGESTS PIGEON DROPPINGS AS A SOURCE OF PATHOGENIC CRYPTOCOCCUS-NEOFORMANS SEROTYPE-D

      Journal of clinical microbiology
    71. KING PD; SADRA A; BELL GM; HAN A; DUPONT B
      MEDIATED ACTIVATION OF THE TEC FAMILY KINASE, EMT ITK, IS CONTROLLED BY ONE OF 6 PROLINE-RICH STRETCHES PRESENT IN THE CD2 CYTOPLASMIC TAIL/

      Journal of allergy and clinical immunology
    72. BODMER JG; MARSH SGE; ALBERT ED; BODMER WF; BONTROP RE; CHARRON D; DUPONT B; ERLICH HA; FAUCHET R; MACH B; MAYR WR; PARHAM P; SASAZUKI T; SCHREUDER GMT; STROMINGER JL; SVEJGAARD A; TERASAKI PI
      NOMENCLATURE FOR FACTORS OF THE HLA SYSTEM, 1996

      Vox sanguinis
    73. GACHOT B; ELIASZEWICZ M; DUPONT B
      ARTESUNATE AND CEREBELLAR DYSFUNCTION IN FALCIPARUM-MALARIA

      The New England journal of medicine
    74. AUGUST A; SADRA A; DUPONT B; HANAFUSA H
      SRC-INDUCED ACTIVATION OF INDUCIBLE T-CELL KINASE (ITK) REQUIRES PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY AND THE PLECKSTRIN HOMOLOGY DOMAIN OF INDUCIBLE T-CELL KINASE

      Proceedings of the National Academy of Sciences of the United Statesof America
    75. BULLARD DC; KING PD; HICKS MJ; DUPONT B; BEAUDET AL; ELKON KB
      INTERCELLULAR-ADHESION MOLECULE-1 DEFICIENCY PROTECTS MRL MPJ-FAS(IPR) MICE FROM EARLY LETHALITY/

      The Journal of immunology
    76. KING PD; SADRA A; TENG JMC; LIU XR; HAN A; SELVAKUMAR A; AUGUST A; DUPONT B
      ANALYSIS OF CD28 CYTOPLASMIC TAIL TYROSINE RESIDUES AS REGULATORS ANDSUBSTRATES FOR THE PROTEIN-TYROSINE KINASES, EMT AND LCK

      The Journal of immunology
    77. SIMMONS D; DUPONT B; LEACH RJ; KARRMAN C; BACKMAN B; HOLMGREN G; FORSMAN K; MACDOUGALL M
      AMELOBLASTIN - CANDIDATE GENE FOR THE AUTOSOMAL-DOMINANT AMELOGENESISIMPERFECTA (ALH2)

      Journal of dental research
    78. BANI L; DAVID D; FEVRIER M; PIALOUX G; DUPONT B; SUGAMURA K; THEZE J
      INTERLEUKIN-2 RECEPTOR-BETA AND GAMMA-CHAIN DYSREGULATION DURING THE INHIBITION OF CD4 T-CELL ACTIVATION BY HUMAN IMMUNODEFICIENCY VIRUS-1 GP120

      European Journal of Immunology
    79. SUZUKI T; TAI H; YOSHIE H; JEANNEL D; FOURNIER S; DUPONT B; DETHE G; HARA K
      CHARACTERIZATION OF HIV-RELATED PERIODONTITIS IN AIDS PATIENTS - HIV-INFECTED MACROPHAGE EXUDATE IN GINGIVAL CREVICULAR FLUID AS A HALLMARKOF DISTINCTIVE ETIOLOGY

      Clinical and experimental immunology
    80. FOURNIER S; DUPONT B
      EFFICACY AND TOLERANCE OF LIPOSOMAL DAUNORUBICIN IN KAPOSI-SARCOMA ASSOCIATED WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

      Archives of dermatology
    81. LORTHOLARY O; DUPONT B
      AZOLE ANTIFUNGAL PROPHYLAXIS IN NEUTROPEN IC PATIENTS AND BONE-MARROWGRAFT RECIPIENTS

      Annales de medecine interne
    82. DUPONT B
      HISTOCOMPATIBILITY TESTING FOR HLA CLASS-I

      Tissue antigens
    83. BOZON MV; DELGADO JC; SELVAKUMAR A; CLAVIJO OP; SALAZAR M; OHASHI M; ALOSCO SM; RUSSELL J; YU N; DUPONT B; YUNIS EJ
      ERROR RATE FOR HLA-B ANTIGEN ASSIGNMENT BY SEROLOGY - IMPLICATIONS FOR PROFICIENCY TESTING AND UTILIZATION OF DNA-BASED TYPING METHODS

      Tissue antigens
    84. DUPONT B; SELVAKUMAR A; STEFFENS U
      THE KILLER-CELL INHIBITORY RECEPTOR GENOMIC REGION ON HUMAN-CHROMOSOME 19Q13.4

      Tissue antigens
    85. SELVAKUMAR A; STEFFENS U; PALANISAMY N; CHAGANTI RSK; DUPONT B
      GENOMIC ORGANIZATION AND ALLELIC POLYMORPHISM OF THE HUMAN KILLER-CELL INHIBITORY RECEPTOR GENE KIR103

      Tissue antigens
    86. BODMER JG; MARSH SGE; ALBERT ED; BODMER WF; BONTROP RE; CHARRON D; DUPONT B; ERLICH HA; FAUCHET R; MACH B; MAYR WR; PARHAM P; SASAZUKI T; SCHREUDER GMT; STROMINGER JL; SVEJGAARD A; TERASAKI PI
      NOMENCLATURE FOR FACTORS OF THE HLA SYSTEM, 1996

      Tissue antigens
    87. GUILLOT J; GUEHO E; LESOURD M; MIDGLEY G; CHEVRIER G; DUPONT B
      IDENTIFICATION OF MALASSEZIA SPECIES - A PRACTICAL APPROACH

      Journal de mycologie medicale
    88. DROMER F; RONIN O; IMPROVISI L; DUPONT B
      VALUE AND LIMITS OF BICHRO-LATEX ALBICANS (R) FOR THE RAPID IDENTIFICATION OF CANDIDA-ALBICANS

      Journal de mycologie medicale
    89. DROMER F; DUPONT B
      THE INCREASING PROBLEM OF FUNGAL-INFECTIONS IN THE IMMUNOCOMPROMISED HOST

      Journal de mycologie medicale
    90. EDELMAN L; DEVEAU C; RAPHAEL M; MONCHATRE E; GABARRE J; DEVILLECHABROL A; PIALOUX G; EMILIE D; JOAB I; GALANAUD P; ROUZIOUX C; BARY M; BURGARD M; GALLAIS H; MARS ME; GALLAIS J; DELLAMONICA P; PERBOST I; CARLES M; CASSUTO JP; REBOULOT B; QUARANTA M; LEFRERE JJ; LERABLE J; JOUBERT L; DUPONT B; BEUZELIN C; FOURNIER S; DORMONT J; DELFRAISSY JF; LEVY A; BOUE F; VITTECOQ D; BOLLIOT C; PECHALAT MT; LEBRAS P; GOUJARD C; QUERTAINMONT Y; GASTAUT JA; DHIVER C; DROGOUL MP; GAZENGEL C; PERTUISSET N; ROTSCHILD M; HERSON S; COUTELLIER A; SERENI D; GOMEZ V; BACHMEYER C; VILDE JL; LEPORT C; COLASSANTE U; PEYNET J; LAUX C; KATLAMA C; BRUCKER G; LAURIAN Y; KEBEDJI L; LAMBERT T; SOBEL A; DUVAL J; MAJERHOLE C; DEFORGES L; KAZATCHKINE M; VELLAY A; BUISSON M; SULTAN Y; GAUTREAU C; PICARD F; GUILLEVIN L; LAROUSSE B; TROGOFF B
      SERUM INTERLEUKIN-10 IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME LYMPHOMA PATIENTS

      European cytokine network
    91. DEGA H; ELIASZEWICZ M; GISSELBRECHT M; FLEURY J; PIALOUX G; JANSSEN B; DESAINTMARTIN L; GONZALEZCANALI G; DUPONT B
      INFECTIONS ASSOCIATED WITH TOTALLY IMPLANTABLE VENOUS ACCESS DEVICES (TIVAD) IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS

      Journal of acquired immune deficiency syndromes and human retrovirology
    92. FLANDRE P; BOUFASSA F; GERARD L; CARRE N; PERSOZ A; MEYER L; ROUZIOUX C; BARY M; BURGARD M; DELLAMONICA P; DURANT J; GALLAIS H; MARS ME; GALLAIS J; DORMONT J; DELFRAISSY JF; LEVY A; BOUE F; LEFRERE JJ; LERABLE J; JOUBERT L; CASSUTO JP; REBOULOT B; QUARANTA M; DUPONT B; BEUZELIN C; FOURNIER S; VITTECOQ D; BOLLIOT C; PECHALAT MT; HERSON S; COUTELLIER A; GASTAUT JA; DHIVER C; DROGOUL MP; SERENI D; GOMEZ V; BACHMEYER C; VILDE JL; LEPORT C; COLASSANTE U; KATLAMA C; BRUCKER G; SOBEL A; DUVAL J; MAJERHOLD C; DEFORGES L; KAZATCHKINE M; VELLAY A; BUISSON M; LEBRAS P; GOUJARD C; QUERTAINMONT Y; ANDRIEU JM; EVEN P; GUILLEVIN L; JAROUSSE B; TROGOFF B
      THE USE OF AUXILIARY EVENTS TO IMPROVE THE ANALYSIS OF SURVIVAL FOR HIV-INFECTED PATIENTS - APPLICATION TO THE FRENCH PROSPECTIVE MULTICENTER COHORT (SEROCO)

      Journal of acquired immune deficiency syndromes and human retrovirology
    93. DROMER F; MATHOULIN S; DUPONT B; LAPORTE A; CHARDON H; GREZE H; HAYETTE MP; CHABASSE D; MARTIN M; PULIK M; HAUTEFORT B; LEPENNEC MP; LARFOUILLOUX J; FALLER JP; BARALE T; BOUGESMICHEL C; DELZANIG G; COUPRIE B; BOUGNOUX ME; MASURE O; LEFORT C; DUHAMEL C; BIDAULT C; ZAEGEL M; ALLARD C; LAURENS E; DORMONT J; BEYTOUT J; MOLLO JL; BOUSSOUGANT Y; CORDIER F; BRETAGNE S; GAILLARD JP; PORTIER H; GRISE G; LEBLANC A; BOUCHARD I; NAUCIEL C; LEBEAU B; BOUREE P; LAGARDE A; VINCENT J; DESAILLYCHANSON MA; ELOY O; GRILLOT ML; GOSSET X; CAPBERN P; DARDE ML; LEMERCIER Y; PIENS MA; JANIN G; TREMOLIERES F; QUILICI M; EME A; PIQUET M; REYNES J; GETTLER V; TREVOUX A; KURES L; MORIN O; KERNBAUM S; GARITOUSSAINT M; DELAGE A; BARTHEZ JP; GIUDICELLI Y; JACQUEMIN JL; BOUVRY M; PATEYRON F; TOUBAS D; GUIGEN C; BRASSEUR C; LAFAYE JMP; SIRONDELLE G; GAUTHRON M; JANVIER M; GODINEAU N; DORCHE G; FEGUEUX S; ROUE R; SIMONEAU M; MALHERBE P; KOENIG H; CAHEN P; MUZELLEC Y; LINAS MD; BAIXENCH MT; DECLOSETS F; VERGER J; SALIBA F; PATEY O; DATRY A; LAVARDE V; DERECONDO J; PONSOT G; LAMER C; HENNEQUIN C; TRAORE F; ARBORIO M; DEMATONS C; ROUX P; CHOCHILLON C; DELUOL AM; POIROT JL; DUPOUYCAMET J; BLANC V; BASSET D
      EPIDEMIOLOGY OF CRYPTOCOCCOSIS IN FRANCE - A 9-YEAR SURVEY (1985-1993)

      Clinical infectious diseases
    94. DROMER F; MATHOULIN S; DUPONT B; LETENNEUR L; RONIN O; CHARDON H; HAYETTE MP; BOUCHARA P; HAUTEFORT B; LEPENNEC MP; LARFOUILLOUX J; FALLER M; REBOUX G; COUPRIE B; BOUGNOUX ME; MASURE O; LEFORT C; DUHAMEL C; ZAEGEL M; CAMBON M; BOUSSOUGANT Y; BRETAGNE S; GESLIN M; BERTHELOT M; CAMERLYNCK P; GRISE G; GAUTHIER M; BOUCHARD I; NAUCIEL C; LEBEAU B; ROMAND S; DESAILLYCHANSON MA; ELOY O; GRILLOT ML; BOYER E; GOSSET X; BOUTEILLE B; PIENS MA; JANIN G; TREMOLIERES F; NGUYEN M; EME A; RASPAIL P; KURES L; MORIN O; FELZ M; LEFICHOUX Y; DELAGE A; BARTHEZ JP; NOUAILHAT F; LACROIX C; BLANCHARD A; TOUBAS D; CHEVRIER S; BRASSEUR C; LAFAYE JMP; GODINEAU N; DORCHE G; ROUE R; WALLER J; CAHEN P; MUZELLEC Y; LINAS MD; BAIXENCH MT; VINOCOUR M; VERGER M; RIOU R; ROMAN S; PATEY O; DATRY A; LAVARDE V; DERECONDO J; PONSOT G; LAMER C; HENNEQUIN C; TRAORE F; ARBORIO M; DEMATONS C; ROUX P; CHOCHILLON C; DELUOL AM; BUOT G; POIROT JL; DUPOUYCAMET J; BLANC V; SEGONDS M
      INDIVIDUAL AND ENVIRONMENTAL-FACTORS ASSOCIATED WITH INFECTION DUE TOCRYPTOCOCCUS-NEOFORMANS SEROTYPE-D

      Clinical infectious diseases
    95. HENNEQUIN C; BOUREE P; HIESSE C; DUPONT B; CHARPENTIER B
      SPONDYLODISKITIS DUE TO CANDIDA-ALBICANS - REPORT OF 2 PATIENTS WHO WERE SUCCESSFULLY TREATED WITH FLUCONAZOLE AND REVIEW OF THE LITERATURE

      Clinical infectious diseases
    96. MOULIGNIER A; MIKOL J; GONZALEZCANALI G; POLIVKA M; PIALOUX G; WELKER Y; ALAIN S; THIEBAUT JB; DUPONT B
      AIDS-ASSOCIATED CYTOMEGALOVIRUS-INFECTION MIMICKING CENTRAL-NERVOUS-SYSTEM TUMORS - A DIAGNOSTIC CHALLENGE

      Clinical infectious diseases
    97. KATLAMA C; DEWIT S; ODOHERTY E; VANGLABEKE M; CLUMECK N; PAYEN MC; MATHIESEN L; NIELSEN JO; PEDERSEN C; DUPONT B; PIALOUX G; JANBON F; REYNES J; GALLAIS H; MARS ME; JEANTILS V; SCHNEIDER MC; AVEROUS V; DECAZES JM; DOCOLECOMPTE T; MODAI J; MOLINA JM; BLANC A; DELFRAISSY JF; GUILLEVIN L; JARROUSSE B; SEHOUANE R; TROGOFF B; ARMENGAUD M; MARCHOU B; MEURISSE JJ; GENTILINI M; GUICHARD A; ROGEAUX O; LIVROZET JM; TOURAINE JL; SERENI D; ROUSSEAU F; PESCE A; COULAUD JP; DETRUCHIS P; FEGUEUX S; MASLO C; MATHERON S; RAFFI F; BASSETTI D; CANESSA A; DELBONO V; DELEO P; TERRAGNA A; ANTINORI A; DAMIANO F; ORTONA L; PALLAVICINI F; TAMBURRINI E; ANGARANO G; CARBONARA S; PASTORE G; PORTEGIES P; REISS P; COSTA J; MACHADO J; MALTEZ F; MORGADO A; PROENCA R; ANTUNES F; CARVALHO C; DOROANA M; DUARTE N; ARAUJO C; CHAMPALIMAUD JL; COSTA J; MANSINHO K; SEIXAS J; LACRUZ J; LOPEZALDEGUER J; GATELL JM; GUELAR A; MALLOLAS J; MIRO JM; ZAMORA L; CLOTET B; JOU A; RAVENTOS A; ROMEU J; SIRERA G; BOLAO F; CASANOVA A; GUDIOL F; PODZAMCZER D; GAZAPO E; GONZALEZLAHOZ JM; BLANCO LM; MORENO V; POLO R; MARTINEZ MC; SANZ J; VERDEJO J; COSIN J; MIRALLES P; MORENO S; PEREZTASCON O; HIRSCHEL B; PERRIER A; RASSAERT C; SOMMEREIJNS B; UBRICH V; BERLUREAU P; DORMONT J; LEVY JP; MEUNIER F; MIGNOLET F; VANGLABEKE M; VANPOTTELSBERGE C
      PYRIMETHAMINE-CLINDAMYCIN VS PYRIMETHAMINE-SULFADIAZINE AS ACUTE AND LONG-TERM THERAPY FOR TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS

      Clinical infectious diseases
    98. DROMER F; MATHOULIN S; DUPONT B; BRUGIERE O; LETENNEUR L
      COMPARISON OF THE EFFICACY OF AMPHOTERICIN-B AND FLUCONAZOLE IN THE TREATMENT OF CRYPTOCOCCOSIS IN HUMAN-IMMUNODEFICIENCY-VIRUS-NEGATIVE PATIENTS - RETROSPECTIVE ANALYSIS OF 83 CASES

      Clinical infectious diseases
    99. KING PD; SADRA A; HAN A; LIU JR; SUNDERPLASSMANN R; REINHERZ EL; DUPONT B
      CD2 SIGNALING IN T-CELLS INVOLVES TYROSINE PHOSPHORYLATION AND ACTIVATION OF THE TEC FAMILY KINASE, EMT ITK/TSK/

      International immunology
    100. MOULIGNIER A; ELIASZEWICZ M; MIKOL J; POLIVKA M; THIEBAUT JB; DUPONT B
      SPINAL-CORD COMPRESSION DUE TO CONCOMITANT PRIMARY LYMPHOMA AND MYCOBACTERIUM-AVIUM-INTRACELLULARE INFECTION OF THE PARAVERTEBRAL MUSCLES IN AN AIDS PATIENT

      European journal of clinical microbiology & infectious diseases


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/02/20 alle ore 23:52:20